Immunoglobulin D benign monoclonal gammopathy. A case report
- 1 August 1991
Abstract
The authors report a case, perhaps the first, of immunoglobulin D (IgD) benign monoclonal gammopathy. The patient, a 48-year-old black woman, initially had a 500 mg/dl IgD-lambda M-spike, hypercalcemia, and anemia. There was no bone pain, lytic bone lesions, or evidence of renal failure. The bone marrow showed 2.8% plasma cells with a diffuse (not nodular) IgD plasmacytosis and strong lambda predominance. Only trace amounts of free lambda light chains could be demonstrated by immunoelectrophoresis in serum and concentrated urine. The anemia responded quickly to iron therapy. Chemotherapy was not initiated. Over the 6+ years of follow-up, the patient has had no progression of clinical disease attributable to her IgD monoclonal gammopathy. The IgD M-spike has steadily decreased.Keywords
This publication has 9 references indexed in Scilit:
- IgD-λ monoclonal gammaopathy and axonal neuropathyJournal of Internal Medicine, 1989
- Histologic Classification and Staging of Multiple Myeloma: A Retrospective and Prospective Study of 674 CasesAmerican Journal of Clinical Pathology, 1987
- Prognostic factors in IgD myeloma: A study of 21 casesScandinavian Journal of Haematology, 1984
- 'Benign' Monoclonal GammopathyPublished by American Medical Association (AMA) ,1984
- The Physiopathological Significance of Benign Monoclonal Gammopathy: a Study of 64 CasesBritish Journal of Haematology, 1980
- Smoldering Multiple MyelomaNew England Journal of Medicine, 1980
- Monoclonal gammopathy of undetermined significanceAmerican Journal Of Medicine, 1978
- IgD Multiple MyelomaArchives of Internal Medicine, 1975
- Melphalan and prednisone: An effective combination for the treatment of multiple myelomaAmerican Journal Of Medicine, 1973